Bucillamine
Bucillamine (DE019) is an orally active sulfhydryl donor and antioxidant with antirheumatic and antiangiogenic properties. It has demonstrated protective effects against ischemia/reperfusion injury in transplant models and inhibits VEGF production, making it relevant for research in rheumatoid arthritis, choroidal neovascularization, and organ transplantation.
Product Specifications
CAS Number
65002-17-7
Product Name Alternative
DE 019, DE019, DE-019, Inhibitor, inhibit, Ischemia/reperfusion, choroidal neovascularization, Bucillamine, antirheumatic, Antioxidant, antioxidant, antiangiogenic, Vascular endothelial growth factor receptor, VEGFR, rheumatoid arthritis, SA 96, SA96, SA-96, Thiobutarit, Tiobutarit
Field of Research
Cardiovascular Research, Metabolism Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
98.66% (May vary between batches)
Solubility
DMSO:25 mg/mL (111.95 mM)
Smiles
[C@@H] (NC (C (C) (C) S) =O) (C (O) =O) CS
Molecular Formula
C7H13NO3S2
Molecular Weight
223.31
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
127865-HRP 100 µL
HIPK1 (Homeodomain-interacting Protein Kinase 1, Nuclear Body-associated Kinase 2, KIAA0630, MYAK, NBAK2, MGC26642, MGC33446, MGC33548) (HRP)
Sign In for Pricing
View Details 
132742-ML750 100 µL
RP2 (Protein XRP2, KIAA0215) (MaxLight 750) discontinued
Sign In for Pricing
View Details